Quest Diagnostics has developed a digitized version of the Memory Orientation Assessment Test, called MOST, to assess patients with cognitive dysfunction, such as Alzheimer’s disease or dementia.

The product is CogniSense, which integrates assessment results into a patient’s electronic health record, where disease progression can be tracked over time, says Edward Ginns, MD, a practicing neurologist and medical director of neurology at Quest.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access